Team from Bristol Children’s Hospital presenting research at Paediatric Infectious Diseases Conference in Slovenia
A clinical team from Bristol Children’s Hospital presented research data at the European Society for Paediatric Infectious Diseases (ESPID) Annual Meeting 2019. The team, led by Adam Finn, CRN Clinical Divisional Lead for Division 3, presented at the conference which took place in Ljubljana, Slovenia, from 6th to 11th May 2019.
The team presented on a variety of topics, including varicella surveillance data gathered at Bristol Children’s Hospital. Varicella, also commonly referred to as “chickenpox”, is an acute and highly contagious disease. This research is associated with the QoL-PoX study, which aims to provide good quality data on chickenpox complication rates and effect on quality of life. The QoL-PoX study research was requested by the Joint Committee on Vaccination and Immunisation (JCVI), who aim to reassess the cost-utility for chickenpox vaccines in the UK.
The QoL-PoX study research presented by the Bristol Children’s Hospital clinical team examines all admissions due to chickenpox over 12 months. The data is divided into diagnostic categories, as well as median age and duration of hospitalisation by diagnosis.
As well as presenting this data, the team presented information on a range of paediatric infection research. This included successful outpatient parenteral antibiotic therapy (p-opat), meningococcal carriage and vaccines, pneumococcal carriage, cases of acute paralysis, changing trends of paediatric tuberculosis, a case report of unusual typhoid infection, and antibiotic prescribing. The team also included a student presentation on Empyema treatment in children. Empyema is the medical term for pockets of pus that have collected inside a body cavity, most commonly the pleural cavity in the lungs.
Many congratulations to the whole team!